Why do we use cryoablation?
Tumor ablation is more important to aim at Prolong survival period and improve quality of life.
Cancer is a chronic disease which can be controlled.Ablation is one of the most effective means to control progressive parenchyma tumor.
Cryosurgery is a novel technique for treatment of cancer which has been approved by the United States~ Food & Drug Administration (FDA) in 1998 and China~s SFDA in 1999.Fuda Cancer Hospital-Guangzhou has used the technique since 2000. To date, Fuda has the greatest amount of experience in this minimally invasive operation; often Fuda trains doctors from around the world on the cryosurgery technique. And number of cryosurgery cases has nearly topped 8,000 cases with a variety of malignant tumors (more than 34 different kinds of cancers). At the same time, Combined the new idea of " 3C+P" (Cryoablation, Combined immunotherapy, Cancer mincrosphere intervention, Personalized therapy) treatment model has been successful to apply to treat a variety of cancers too,
In the latest edition of NCCN guidelines, cryoablation has been recommended for unresectable cancers. For example:
Cryoablation is an local regional therapy for Hepatocellular Carcinoma (HCC)
cryo-therapy is a preferred local treatment modality in Surgical therapy for Non-small Cell Lung Cancer.
Ablation techniques can be considered when Colon cancer have been metastases
Use of cryoablation in Fuda
1.“Radical” eradication of “small” cancer
2.“Debulky” for unresectable tumors
3.Freezing-assisted operation
1.To alleviate pain caused by tumor
8000 patients treated by cryoablation in Fuda
Two types of cryosurgical equipment designed to use in Fuda
Percutaneous cryoablation under CT or US
No.1 “Radical” eradication
Those patients who cannot undergo operation due to weak condition or co-morbidity, and those who refuse to receive operation, percutaneous cryoablation is to achieve great efficacy for cancer and even get cancer cured.
Unresectable, metastases on operation, no response on chemo/radio and recurrent advanced cancer
No comments:
Post a Comment